v1
Rationale for the Clinical Use of Less Frequent Dosing of Mogamulizumab for T-Cell Lymphomas Using Population Pharmacokinetic and Exposure Response Analysis
NobleIDNI2P27W50R85S82
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260521/2DF2DC09)
ARK Inflections
Metadata Formats
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims